Button Capital

Xcision Medical Systems, LLC is a medical technology company focused on developing innovative stereotactic radiotherapy solutions aimed at enhancing cancer treatment. The company specializes in manufacturing radiosurgery devices specifically designed for breast cancer treatment. Its technology utilizes stereotactic gamma irradiation, allowing for a complete course of radiation therapy to be delivered in a single, noninvasive session. This approach significantly reduces the duration of treatment compared to traditional methods, while minimizing radiation exposure to surrounding healthy tissues, including the lungs and heart. As a result, patients can resume their daily activities more quickly and with less discomfort, ultimately improving their quality of life. Additionally, Xcision's advancements enable healthcare professionals to enhance the overall quality of cancer care they provide.

Quest Genomics is a biotechnology research and development company. They provide products that include digital PCR and NGS-related equipment, consumables, and reagents for clinical testing equipment. Their customers' inquiries are addressed through phone, email, and online applications.

Epintek is a company focused on the biomedical and medical device sectors, specializing in contract research organization (CRO) services. It offers a range of services including preclinical research, inspection, and testing for medical institutions and equipment manufacturers. By providing integrated regulatory services, Epintek assists clients with registration and clinical trial processes, ensuring reliable and thorough preclinical inspection of medical devices. Its expertise supports the development and compliance of innovative healthcare solutions.

Sinorda Biomedicine Ltd. is a China-based company specializing in drug development, particularly in the field of small molecules and T cell cancer immunotherapeutics. The company is dedicated to advancing tumor immunotherapy, offering a range of treatment programs that include anti-tumor sentinel lymph node T cell therapy, oncolytic virus therapy, tumor-infiltrating T cell therapy, natural killer cell therapy, dendritic cell therapy, killer T cell therapy, and tumor immune index monitoring. Additionally, Sinorda provides services such as immune cell isolation and cryopreservation, alongside accurate genetic testing and immune function assessments. With a focus on innovation and industrialization, the company is actively engaged in the research, development, and clinical trial stages of its therapeutic offerings.

iBanker is an education management startup based in Beijing that focuses on financial online education. The company aims to be the premier learning platform for financial and quasi-financial practitioners in China. iBanker offers a wide range of multi-tier financial practice courses, covering topics such as investment banking, industry research, asset management, and financial analysis. This diverse curriculum is designed to meet the educational needs of users across various workplaces, enhancing their professional skills and knowledge in the financial sector.

LAKEbio to provide a series of liquid biopsies preservation products based on gene detection and other new technologies.